Transplantologiya. The Russian Journal of Transplantation

Journal Information
ISSN / EISSN : 20740506 / 25420909
Current Publisher: IPO Association of Transplantologists (10.23873)
Total articles ≅ 87
Current Coverage
DOAJ
Archived in
SHERPA/ROMEO
Filter:

Latest articles in this journal

B. I. Yaremin, P. Kh. Nazarov, K. F.O. Alekberov, D. Yu. Konstantinov, E. V. Kudinova, U. V. Maslikova, M. S. Novruzbekov
Transplantologiya. The Russian Journal of Transplantation, Volume 12; doi:10.23873/2074-0506-2020-12-2-135-142

Abstract:
Changes in current scientific literature and regulatory documents related to the issues of infectious safety in organ and tissue donation have been analyzed. The suggestions have been given for changing the existing practices to meet new challenges. Data on threats to the safety of organ and tissue donation associated with the COVID-19 pandemic have been presented.
S. V. Zhuravel, N. K. Kuznetsova, I. I. Utkina, M. S. Novruzbekov, P. V. Gavrilov, T. V. Chernenkaya, G. K. Ospanova
Transplantologiya. The Russian Journal of Transplantation, Volume 12; doi:10.23873/2074-0506-2020-12-2-104-111

The publisher has not yet granted permission to display this abstract.
S. P. Glyantsev
Transplantologiya. The Russian Journal of Transplantation, Volume 12; doi:10.23873/2074-0506-2020-12-2-143-154

The publisher has not yet granted permission to display this abstract.
V. E. Syutkin, N. V. Borovkova, M. S. Novruzbekov
Transplantologiya. The Russian Journal of Transplantation, Volume 12; doi:10.23873/2074-0506-2020-12-2-126-134

The publisher has not yet granted permission to display this abstract.
N. K. Kuznetsova, V. E. Aleksandrova, I. I. Utkina, A. M. Talyzin, S. V. Zhuravel
Transplantologiya. The Russian Journal of Transplantation, Volume 12; doi:10.23873/2074-0506-2020-12-2-94-103

The publisher has not yet granted permission to display this abstract.
S. A. Borzenok, T. Z. Kerimov, N. A. Gavrilova, Yu. Yu. Kalinnikov, M. Kh. Khubetsova, A. A. Zheltonozhko
Transplantologiya. The Russian Journal of Transplantation, Volume 12; doi:10.23873/2074-0506-2020-12-2-112-125

The publisher has not yet granted permission to display this abstract.
O. A. Levina, Anatoliy Konstantinovich Evseev, M. Sh. Khubutiya, A. V. Babkina, A. K. Shabanov
Transplantologiya. The Russian Journal of Transplantation, Volume 12; doi:10.23873/2074-0506-2020-12-1-28-41

Abstract:
The ability to eliminate any form of oxygen debt by transporting oxygen to organs and tissues, by dissolving it in body fluids, brings hyperbaric oxygenation to a new level of application in transplantology. The review discusses the pathophysiological aspects of hyperbaric oxygenation during ischemia and reinfusion, especially when used in transplantology, and also investigations on the use of hyperbaric oxygenation in model experiments and in clinical practice. Analysis of the efficacy of hyperbaric oxygenation therapy at various stages of the transplantation process (preconditioning, donation, organ storage, in the early and late post-transplant periods) allows us to conclude that this method should be more widely involved in transplantation practice.Authors declare no conflict of interest.
F. Hackl, A. V. Kopylov, M. D. Kaufman
Transplantologiya. The Russian Journal of Transplantation, Volume 12; doi:10.23873/2074-0506-2020-12-1-49-60

Abstract:
Cardiac complications are currently the leading cause of early mortality following liver transplantation. Guidelines for the cardiac workup prior liver transplantation are limited. In this review we are discussing commonly modalities used for cardiovascular evaluation of liver transplant candidates.Authors declare no conflict of interest.
Ksenia Y. Kokina, Yu. O. Malinovskaya, Алексей Сидоренко, Ya. G. Moisyuk
Transplantologiya. The Russian Journal of Transplantation, Volume 11; doi:10.23873/2074-0506-2019-11-4-320-329

Abstract:
Recent statistics have shown increased rates of morbidity and mortality from Clostridium difficile infection worldwide. This problem is mainly typical for surgical patients and is associated with an antibiotic therapy and a prolonged hospital stay. Recipients of solid organs are at a high risk of developing severe forms of C. difficile infection due to immunosupression. Existing recommendations for the treatment of C. difficile infection are based on the severity of the disease and do not consider patients after liver transplantation. The aim of this work is to determine an actual tactics for the diagnosis and treatment of C. difficile in organ recipients in clinical practice.
Rustam Akalaev, G. Z. Aripkhodzhaeva, S. A. Rashidova, A. N. Abdullaev, K. A. Khashimov
Transplantologiya. The Russian Journal of Transplantation, Volume 11; doi:10.23873/2074-0506-2019-11-4-282-289

Abstract:
Background. Today, the programmed hemodialysis belongs to the clinical medicine area where patients are at a constant risk of viral hepatitis infection. This is associated with surgical interventions on the vessels, fairly frequent transfusions of blood components, and regular hemodialysis procedures. But in recent years, the ratio of reported cases of viral hepatitis B and C in patients on programmed hemodialysis has changed significantly. With an abrupt increase in the incidence of viral hepatitis C, there is a decrease in the number of registered viral hepatitis B cases.The aim. To study the clinical, epidemiological and pathogenetic features of viral hepatitis C in hemodialysis units.Material and methods. A multicenter study was conducted that enrolled the patients from the Programmed Hemodialysis Units in Tashkent and the regional departments of the Republic of Uzbekistan. The study involved 395 patients on programmed hemodialysis for 7.5 ± 0.7 years. The age of patients was 43.5 ± 0.91 years. The diagnosis of chronic viral hepatitis C was made on the basis of medical history, clinical and laboratory data, and detection of anti-HCV IgG and RNA-HCV in blood.Results. When analyzing the clinical examination and laboratory test results of 395 patients, the parenteral viral infection markers were detected in 181 patients (45.8%). The analysis of the overall incidence of viral hepatitis showed that chronic viral hepatitis C had the highest rates and was found in 125 patients (31.6%). The analysis of the chronic viral hepatitis C course in the presence of the end-stage chronic renal disease showed that in 11 (34%) of 32 patients of the Main group the disease proceeded as a fulminant form of chronic renal-hepatic failure with the development of adverse outcomes. Twenty seven patients (84%) in this group developed progressive anemia. In 16 patients (50%), persistent polyserositis developed in the form of hydrothorax, ascites, and pericarditis, which reflected the aggravating effect of chronic viral hepatitis C on the course of chronic renal disease.Conclusions. In Hemodialysis Units, both in the city of Tashkent, and in the regional departments of the Republic of Uzbekistan, the incidence of chronic viral hepatitis C prevails, having the form of a pathological process with a minimally low activity. Chronic viral hepatitis C has an aggravating effect on the course of the underlying disease with the development of adverse outcomes.
Back to Top Top